2017-现在科研基金：

1.广东省自然科学基金，项目名称：维持神经血管稳态在帕金森病防治中的作用及机制研究，项目编号：2017A030311010，总经费：50万元

2.国家自然科学基金，项目名称：IRE1α-Parkin信号通路在多巴胺能神经元线粒体自噬障碍及凋亡中的作用机制，项目编号：81873777，总经费：56万元, 项目起止年月：2019年1月-2022年12月

3.广东省省级科技计划项目（国际科技合作领域），项目名称: 肠道菌群介导的Cystatin C-Cathepsins-MHC-II/α-Syn通路对“肠-脑轴”的调节及其在帕金森病发病机制中的作用研究，项目编号：2020A0505100037，总经费：50万元, 项目起止年月：2020年8月-2022年7月

4.国家自然科学基金，项目名称：周细胞介导的PDGF-BB/PDGFR β-IL-33/ST2信号通路在帕金森病中的作用机制，项目编号：82071414，总经费：55万元，项目起止年月：2021年1月-2024年12月

5.国家重点研发慢病项目一级分题，项目名称：帕金森病的新治疗，项目编号：2017YFC1310200，总经费：91万元，2018年1月-2021年12月

在院“人才”经费：

1.广东“特支计划”人才经费，项目名称：广东特支计划百千万工程领军人才，项目编号：014119001，总经费：50万元 

2017-现在发表的文章：

1.Qing Wang*†, Yuqi Luo †, K Ray Chaudhuri, Richard Reynolds, Eng-King Tan*, Sven Pettersson*. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options. Brain. 2021, In press. (IF: 11.7).

2.Wanlin Yang, Bin Deng, Yu Huang, Jingxing Liu, Zifeng Huang, Zihan Chang, Shuzhen Zhu, Ling-Ling Chan, K. Ray Chaudhuri, Eng-King Tan*, Qing Wang*. Two Heterozygous Progranulin mutations in Progressive Supranuclear Palsy. Brain 2021 Apr 12;144(3): e27 (IF: 11.7). 

3.Bin Deng, Zhe Zheng, Jialing Zheng, Wanlin Yang, Yu Huang, Yuqi Luo, Dana Jin, Lu Shen, Kunlin Jin, Qing Wang. FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation. Aging and Disease. 2021, in press. (IF:5.4)

4.Shuzhen Zhu, Bin Deng, Zifeng Huang, Zihan Chang Hualin Li MD 2, Hui Liu 2, Yanjun Huang, Ying Pan, Yanping Wang, Yin-Xia Chao, Ling-Ling Chan, Yih-Ru Wu, Eng-King Tan*, Qing Wang*. ‘Hot cross bun’ is a potential imaging marker for the severity of cerebellar ataxia in MSA-C. NPJ Parkinson’s Disease. 2021, 15, 7 (2021 IF: 8.3).  

5.Xingfang Guo, Bin Deng, Lizi Zhong, Fen Xie, Qing Qiu, Xiaobo Wei, Wenya Wang, Jiangping Xu, Ganqiang Liu, Wong Peter Tsun Hon, Midori A. Yenari, Shuzhen Zhu*, Qing Wang*. Fibrinogen is an independent risk factor for white matter hyperintensities in CADASIL but not in sporadic cerebral small vessel disease patients. Aging and Disease. 2021, in press. (IF:5.4) 

6.Chang Z, Zou H, Xie Z, Deng B, Que R, Huang Z, Weng G, Wu Z, Pan Y, Wang Y, Li M, Xie H, Zhu S, Xiong L, Mok VC, Jin K, Yenari MA, Wei X*, Wang Q*. Cystatin C is a Potential Predictor of Unfavorable Outcomes for Cerebral Ischemia with IV-tPA Treatment: A Multicenter Prospective Nested Case-Control Study. Eur J Neurol. 2020 Dec 4. doi: 10.1111/ene.14663. (IF: 4.6). 

7.Zhu S, Li H, Deng B, Zheng J, Huang Z, Chang Z, Huang Y, Wen Z, Liang Y, Yu M, Chan LL, Tan EK, Wang Q*. Various Diseases and Clinical Heterogeneity Are Associated With "Hot Cross Bun". Front Aging Neurosci. 2020 Nov 20; 12: 592212. doi: 10.3389/fnagi.2020.592212. (IF: 4.5). 

8.Xiaoya Gao, Zifeng Huang, Cailing Feng, Chaohao Guan, Ruidong Li, Haiting Xie, Jian Chen, Mingchun Li, Rongfang Que, Bin Deng, Peihua Cao, Mengyan Li, Jianjun Lu, Yihong Huang, Minzi Li MD, Weihong Yang, Xiaohua Yang, Chunyan Wen, Xiaomei Liang, Qin Yang, Yinxia Chao, Lingling Chan, Midori A. Yenari, Kunlin Jin, K. Ray Chaudhuri, Jing Zhang *, Eng-King Tan *, Qing Wang *. Multi-modal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson’s disease. Briefings in Bioinformatics 2020 Oct 20: bbaa244. doi: 10.1093/bib/bbaa244. (IF: 9.1).  

9.Ting Wang, Feilan Yuan, Zhenze Chen, Shuzhen Zhu, Zihan Chang, Wanlin Yang, Bin Deng, Rongfang Que, Peihua Cao, Yinxia Chao, Lingling Chan, Ying Pan, Yanping Wang, Linting Xu, Qiurong Lyu, Piu Chan, Midori A Yenari, Eng-King Tan*, Qing Wang*. Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus. Aging (Albany NY). 2020; 12(15): 15682-15704 doi: 10.18632/aging.103776. (IF: 4.8).

10.Yuan F, Guo X, Wei X, Xie F, Zheng J, Huang Y, Huang Z, Chang Z, Li H, Guo Y, Chen J, Guo J, Tang B, Deng B*, Wang Q*. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis. Eur J Neurol. 2020 Oct;27(10):1957-1970 (IF: 4.6) 

11.Wanlin Yang, Zihan Chang, Rongfang, Guomei Weng, Bin Deng, Ting Wang, Zifeng Huang, Fen Xie, Xiaobo Wei, Qin Yang, Mengyan Li, Kefu Ma, Fengli Zhou, Beisha Tang, Vincent CT Mok, Shuzhen Zhu*, Qing Wang* Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity. Frontiers in Aging Neuroscience 2020, 12:53. (IF: 4.5). 

12.Wenxia Zheng, Rongni He, Zhenxing Yan, Yaowei Huang, Wei Huang，Zhuoyi Cai, Yuying Su, Siqin Liu, Yiting Deng, Qing Wang*, Huifang Xie*.  Regulation of Immune-Driven pathogenesis in Parkinson’s Disease by Gut Microbiota. Brain Behavior and Immunity. 2020; 87:890-897 (IF: 6.7).   

13.Qin Yang, Zifeng Huang, Yangfu Luo, Fangshuo Zheng, Yida Hu, Hui Liu, Shuzhen Zhu, Miaoqing He, Demei Xu, Yun Li, Min Yang, Yi Yang, Xiaobo Wei, Xiaoya Gao, Wei Wang, Junhong Ma, Yuanlin Ma, Xuefeng Wang*, Qing Wang*. Inhibition of Nwd1 activity attenuates neuronal hyperexcitability and GluN2B phosphorylation in the hippocampus. EBioMedicine 2019 Sep; 47: 470-483 (IF: 6.68).  

14.Shuzhen Zhu, Xiaobo Wei1, Xiaohua Yang1, Zifeng Huang, Zihan Chang, Fen Xie, Qin Yang, Wei Xiang, Hongjun Yang, Changhai Ding, Ying Xia, Zhong-Ping Feng, Hong-Shuo Sun, Midori A. Yenari, Lin Shi, Vincent CT Mok, Qing Wang*. Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment. Aging Dis. 2019;10(4):834-846 (IF: 5.4). 

15.Models of poststroke depression and assessments of core depressive symptoms in rodents: How to choose? Tao X, Yang W, Zhu S, Que R, Liu C, Fan T, Wang J, Mo D, Zhang Z, Tan J, Jin K, Yenari MA, Song T, Wang Q. Exp Neurol. 2019; 322:113060. (IF: 4.6). 

16.Xie F, Gao X, Yang W, Chang Z, Yang X, Wei X, Huang Z, Xie H, Yue Z, Zhou F, Wang Q*. Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease. ACS Chem Neurosci. 2019;10(2):973-990 (IF: 4.4).   

17.Xiaoya Gao, Haiting Xie, Shuzhen Zhu, Bin Yu, Ying Xian, Qian Ouyang, Yabin Ji, Xiaohua Yang, Chunyan Wen, Penghua Wang, Yufeng Tong, Qing Wang*. The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats against Hypoxic-ischemic Encephalopathy-induced Injury by Promoting Angiogenesis and Regeneration. 2018; 10:196 Front Aging Neurosci; (IF: 4.55). 

18.Jing Zou, Zhigang Chen, Caiqian Liang, Yongmei Fu, Xiaobo Wei, Jianjun Lu, Mengqiu Pan, Yue Guo, Xinxue Liao, Huifang Xie, Duobin Wu, Min Li, Lihui Liang, Penghua Wang, Qing Wang *. Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage. Aging and Disease. 2018; 9(1):51-65 (Impact factor: 5.45) 

19.Weng R, Wei X, Yu B, Zhu S, Yang X, Xie F, Zhang M, Jiang Y, Feng ZP, Sun HS, Xia Y, Jin K, Chan P, Wang Q*, Gao X*. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy. Parkinsonism Relat Disord. 2018; 52:37-42 (Impact factor: 4.72). 

20.Jing Zou, Zhaoyu Chen, Xiaobo Wei, Zhigang Chen, Yongmei Fu, Xiaoyan Yang, Dan Chen, Rui Wang , Peter Jenner, Jia-Hong Lu, Min Li, Zhuohua Zhang, Beisha Tang , Kunlin Jin ,  Qing Wang *. Cystatin C as a Potential Therapeutic Mediator against Parkinson's Disease via VEGF-induced Angiogenesis and Enhanced Neuronal Autophagy in Neurovascular Units. Cell Death Dis. 2017; 8(6): e2854 (Impact factor: 5.985). 

21.Rui Wang, Zhaoyu Chen, Yongmei Fu, Xiaobo Wei, Jinchi Liao, Xu Liu, Bingjun He, Yunqi Xu, Jing Zou, Xiaoyan Yang, Ruihui Weng, Sheng Tan, Christopher McElro, Kunlin Jin, Qing Wang* (2017)  Plasma Cystatin C and High-density Lipoprotein are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study. Front Aging Neurosci 2017; 9:26 (Impact factor: 4.55).